DaVita Inc. (NYSE:DVA) Position Boosted by Promethos Capital LLC

Promethos Capital LLC raised its holdings in shares of DaVita Inc. (NYSE:DVA) by 3.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,396 shares of the company’s stock after acquiring an additional 1,000 shares during the period. DaVita makes up 1.5% of Promethos Capital LLC’s holdings, making the stock its 27th largest position. Promethos Capital LLC’s holdings in DaVita were worth $4,396,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of DVA. SBI Securities Co. Ltd. acquired a new stake in DaVita in the fourth quarter worth about $41,000. Venturi Wealth Management LLC boosted its holdings in shares of DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after acquiring an additional 152 shares in the last quarter. Versant Capital Management Inc increased its stake in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares during the period. Blue Trust Inc. raised its holdings in DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after purchasing an additional 131 shares in the last quarter. Finally, Jones Financial Companies Lllp increased its position in shares of DaVita by 28.6% during the 4th quarter. Jones Financial Companies Lllp now owns 517 shares of the company’s stock valued at $77,000 after purchasing an additional 115 shares during the period. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 1.4 %

NYSE:DVA opened at $155.48 on Monday. The business’s fifty day moving average price is $152.13 and its 200 day moving average price is $156.59. The firm has a market capitalization of $12.44 billion, a price-to-earnings ratio of 14.48, a PEG ratio of 1.07 and a beta of 1.04. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, sell-side analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on DVA shares. Barclays lifted their target price on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. StockNews.com upgraded shares of DaVita from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Cowen reiterated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, DaVita has an average rating of “Hold” and an average price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.